chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 17.0
Sex: F
Vaccine: VARCEL
Symptoms: Rubella antibody negative, Syphilis test negative, Ultrasound scan normal, Umbilical cord compression
Clinical narrative: Information has been received from a registered nurse (RN) through a pregnancy registry concerning a 17-year-old Hispanic female with no allergies and a history of urinary tract infection who on 06-DEC-2005 was vaccinated subcutaneously in the right arm with a 0.5 ml dose of Varivax (lot# 647534/0823P). There was no concomitant medication. Soon after the vaccination the patient was found to be pregnant. Unspecified medical attention was sought. Laboratory and diagnostic tests were performed on 10-JAN-2006: prenatal AFP - results pending, "Hep SsAg" - negative, RPR - negative, rubella screen - "reactive," hemoglobin - normal, antibody screen negative for ABO/rhogam-. It was reported that the LMP was 28-OCT-2005 and the EDD = 04-AUG-2006. At the time of the report she was well and it was reported that the physician would be doing ultrasounds for follow-up. NO further information was available. Additional information has been received from a physician. It was reported that the patient had an ultrasound on 13-DEC-2005 for size and due dates. On 22-FEB-2006 she had a standard MSAFP. There were no previous pregnancies and the patient had no local reaction, varicella symptoms or herpes symptoms post vaccination. Additional information received from a registered nurse indicated that on 25-JUL-2006 the woman had a liveborn female infant weighing 2980 41 weeks from the LMP. There were no congenital abnormalities. Complications during pregnancy included thick meconium in fluid and tight nuccal cord X 2. Apgars were 8:9. There were no complications during pregnancy. Diagnostic test during pregnancy were all normal including "afp," ultrasound, and "glucole." Medication used during pregnancy included: prenatal vitamins (5 mg PO daily) and iron (325 mg PO daily) from January 2006 through July 2006. There was no feature of congenital varicella zoster syndrome in the infant. No additional information is expected.
Age: 1.0
Sex: F
Vaccine: HIBV, VARCEL
Symptoms: Injection site inflammation
Clinical narrative: Information has been received from a licensed practical  nurse concerning a 12 month old white female with no allergies or medical history who on24 Jan 2006 was vaccinated SC with a 0.5 mL first dose of Variavax (lot #648314/0071R). Concomitant vaccination on the same day included a fourth IM dose of ActHib (lot # UE774AA). There was no illness at the time of vaccination. On 07 Feb 2006, the patient was seen in the physician's office with inflammation at the injection site. She was started on Ceftin (125/5 6 mL BID x 10 days). The patient's outcome was unknown. A product quality complaint was not involved. Additional information is not expected. s
Age: 1.0
Sex: F
Vaccine: PPV, VARCEL
Symptoms: Pruritus, Rash generalised, Varicella
Clinical narrative: Information has been received from a registered nurse (RN) concerning a 5 year old white female with no allergies and a history of ear tubes, who on 29 Jun 2001 was vaccinated subcutaneously in the left thigh with a first 0.5 ml dose of Variavax (lot # 637973/1884K). Concomitant vaccinations included a dose of Pneumovax. There was no illness at the time of vaccination. On 19 Mar 2006 the patient presented to the office with a spot like rash all over her body with complaints of itching. It was reported that the events began on 17 Mar 2006. It was diagnosed as a chickenpox breakout by the physician. No treatment was provided and no laboratory or diagnostic tests were performed. It was reported that the patient recovered. No product quality complaint was involved. Additional information is not expected.
Age: 1.8
Sex: M
Vaccine: VARCEL
Symptoms: Injection site vesicles
Clinical narrative: Information has been received from a health professional concerning a 34 month old male who on 07 Mar 2006 was vaccinated with a dose of Variavax (Lot # 646539/0551R). On 17 Mar 2006 the patient developed 5 vesicular lesions around the injection site. At the time of the report the patient had not recovered. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Age: 15.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a registered nurse concerning a 21 year old female who on 05-AUG-1999 and in August 2000 was vaccinated with Varivax. There was no concomitant medication. On 07-MAR-2006, the patient had a low varicella titer of 0.45. The patient's outcome was not reported. Additional information has been requested.
Age: 12.0
Sex: M
Vaccine: VARCEL
Symptoms: Pain, Rash, Skin lesion
Clinical narrative: Information has been received from a father concerning his 12 year old son with no medical history or allergies who in 1995 was vaccinated with a dose of Varivax. There was no concomitant therapy. The father reported that on 18 Mar 2006, his son developed a breakthrough rash characterized by about 50 lesions with associated pain at each lesion site. The father noted that the most painful lesions had the largest surface area. The patient was taken to the Emergency Room, but was not admitted. No laboratory/diagnostic tests were performed. It was also noted that the scabbing began "almost immediately." At the time of this report, the patient's breakthrough rash persisted. Additional information has been requested.
Age: 14.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a health professional concerning a 14 year old female with a sulfonamide allergy and no medical history who on 07-SEP-1995 was vaccinated with a 0.5ml dose of Varivax (Oka/Merck) (diluent lot # 513486/1527A). There was no concomitant medication. On 25-FEB-2006 the patient experienced a severe case of chicken pox with greater than 200 lesions. The patient was recovered as of 21-MAr-2006. Unspecified medical attention was sought. No product quality complaint was involved. Follow-up information from a health professional indicated that on 25-FEB-2006 the patient developed a full blown case of chickenpox, with hundreds of lesions. The reporter considered the patient's reaction to be an other important medical event. The patient's brother (WAES 0603USA03382) had a similar reaction after vaccination with Varivax. Additional information is not expected.
Age: 2.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a 12 year old male with no known medical history who on 07-SEP-1995 was vaccinated with a 0.5 mL dose of Varivax (lot # 608582/0410B). There was no concomitant medication. On 27-FEB-2006 the patient developed a severe case of chickenpox greater than 200 lesions noted. Unspecified medical attention was sought. On 21-MAR-2006 the patient recovered. There was no product quality complaint involved. The patient's sister (WAES # 0603USA03381) had a similar experience following vaccination with Varivax. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Pruritus, Rash papular, Skin lesion, Varicella
Clinical narrative: Information has been received from a physician concerning a 5 year old female with no known medical history or allergies who on 04-AUG-2000 was vaccinated SC in the right leg with a first dose of Varivax (lot # 635453/0756K). Concomitant vaccination the same day included a first dose of MMR II (lot # 633097/0255K) given SC in the left leg. There was no illness at the time of vaccination. Subsequently on 17-JAN-2006 the patient developed chicken pox. The patient presented with lesions that were too numerous to count. Follow-up information indicated that the patient had no fever, papules were noted on the trunk and hairline and itching was noted. The patient was seen for a doctor's visit. Treatment included Benadryl elixir and Aveeno bath powder 2-3 times a day. "Isolate" was noted. Subsequently, the patient recovered. There was no product quality complaint involved. It was reported that the patient had no adverse events following prior vaccination. No further information is available.
Age: 7.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a 7 year old female who was vaccinated with a dose of Variavax. In March 2006, the patient experienced breakthrough. At the time of the report the patient was recovering. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. The patient's sister experienced breakthrough following vaccination with Variavax (WAES#0604USA00311). Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse (RN) concerning an elementary aged child who was vaccinated with a dose of Varivax. The RN reported that in February 2006, the patient developed breakthrough chickenpox which was considered to be a light, mild case. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. Additional information has been requested.
Age: 1.0
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a physician concerning a 4 or 5 year old patient who in approximately 2003, at 12 months of age, was vaccinated with a dose of Varivax. Subsequently, the patient experienced breakthrough chickenpox. She had one lesion on the scalp and a "few" on the body. It was a very mild case. Unspecified medical attention was sought. NO product quality complaint was involved. Additional information has been requested.
Age: 8.0
Sex: U
Vaccine: VARCEL
Symptoms: Rash macular, Rash papular, Rash vesicular, Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a health professional concerning a 8 year old child who on 15-APR-1998 was vaccinated with a dose of Varivax. On 01-FEB-2006 the patient developed chickenpox. The child had too many lesions to count, near 500. The lesions were papular, vesicular and macular. Unspecified medical attention was sought. The patient was treated with acyclovir. There was no product quality complaint involved. The reporter considered the patient's chickenpox to be an other important medical event. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a licensed practical nurse concerning a patient who was vaccinated with a dose of Varivax. Subsequently, the patient developed shingles. It was unknown if VZV analysis was done. No details about the child or the timeframe was known. No further information was available. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Age: 1.33
Sex: U
Vaccine: VARCEL
Symptoms: Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a health professional concerning a 16 month old patient who on 12-SEP-2005 was vaccinated with a dose of Varivax (Oka/Merck). On 29-JAN-2006 the patient developed chickenpox. Unspecified medical attention was sought. The patient was treated with acyclovir. There was no product quality complaint involved. The patient's chickenpox was considered to be an other important medical event by the reporter. Additional information has been requested.
Age: 1.67
Sex: M
Vaccine: VARCEL
Symptoms: Body temperature increased, Herpes zoster, Pain, Rash vesicular, Varicella zoster virus serology positive
Clinical narrative: Information has been received from a hospital microbiologist concerning a 20 month old male patient with a history of a recent liver transplant who on 11-AUG-2005 was vaccinated with a history of a recent liver transplant who on 11-AUG-2005 was vaccinated with a 0.5 ml dose of Varivax (lot # 645164/0064R) in the left leg. The patient did not have a rash at the injection sie or elsewhere within 42 days of the vaccination. Concurrent medications included tacrolimus (PROGRAF), lansoprazole (PREVACID),  "florinet" and sulfamethoxazole (+) trimethoprim (BACTRIM). Subsequently the patient experienced herpes zoster like rash on his right thigh. It was reported that the patient was hospitalized. At the time of the report the patient was recovering. Additional information from the physician indicated that on 12-MAR-2006 (also reported as 13-MAR-2006) the patient experienced herpes zoster, dermatome right leg. The patient's maximum temperature was 100.4C and his pain was rated as "3". On 13-MAR-2006 a specimen was collected from a vesicle and was positive for VZV. It was reported that the patient had no recent exposure to chickenpox or herpes zoster. Subsequently the patient recovered. Information received on 04-MAY-2006 indicated that the VZV test was positive for vaccine type strain. The reporter considered the herpes zoster to be an other important medical event. Additional information is not expected.
Age: 1.4
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a licensed practical nurse concerning a 7 year old female who on 06-OCT-1999 was vaccinated with Varivax (lot #631071/1002J). Concomitant therapy included MMR II. On 08-MAR-2007 the patient developed 30 chickenpox lesions with no other symptoms. NO medical attention was sought. Subsequently, the patient recovered. Additional information has been requested.
Age: 30.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from an approximately 30-year-old female registered nurse who was vaccinated with the first, second, third and fourth doses of Varivax. Subsequently, the patient did not develop any antibodies. The outcome was reported as not recovered. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician's office manager concerning a 9-year-old daughter who in approximately 1998, at 1-year-old, was vaccinated with a dose of Varivax. In approximately March 2006, the patient broke out in a chickenpox rash. Subsequently, the patient recovered. No treatment was given. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a medical assistant concerning a 6-year-old female who on 18-NOV-2003 was vaccinated in the right upper arm with a second dose of Varivax (Lot # 646229/0538N). On 08-MAR-2006 the patient broke out with about 20-30 pox total. Subsequently, the patient recovered. Additional information has been requested.
Age: 11.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Information has been received from a mother concerning her 11-year-old son who, at one year of age, was vaccinated with a dose of Varivax. The mother reported that in 2006 her son broke out in a chickenpox-like rash. Unspecified medical attention was sought, but no treatment was given. Subsequently, the patient recovered from the chickenpox-like rash. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Pyrexia, Varicella, Varicella post vaccine, Vomiting
Clinical narrative: Information has  been received from a licensed practical nurse concerning an 8 year old white male with no known medical history or allergies who in April 1998 was vaccinated with a first dose of Varivax. On 15-MAR-2006 the patient developed chickenpox with less than 50 lesions on face, stomach, legs, arms and hips, with vomiting X 1 and a low grade fever. No laboratory diagnostic tests were performed. The patient did not experience any adverse event following prior vaccination. At the time of the report, on 18-MAR-2006, the patient still had an active rash. Follow-up information from the licensed practical nurse indicated that the patient recovered on an unspecified date. Additional information is not expected.
Age: 1.02
Sex: U
Vaccine: VARCEL
Symptoms: Rash maculo-papular
Clinical narrative: Information has been received from a registered nurse (RN) concerning a 14 month old child who on 09 Mar 2006 was vaccinated with a dose of Variavax. The RN reported that in March 2006, the patient developed a maculo-papular rash. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. Additional information is not expected.
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster, Pain, Pruritus
Clinical narrative: Information has been received from a physician concerning a female who was vaccinated with Varivax. Subsequently, "in the past couple of weeks", in approximately March 2006, the patient experienced zoster with pain and itchiness and was hospitalized. It was reported that the patient recovered. No product quality complaint was involved. Additional information has been requested.
Age: 10.0
Sex: M
Vaccine: VARCEL
Symptoms: Blister, Polymerase chain reaction, Scab, Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a licensed practical nurse concerning a 10 year old male who in approximately 1997 was vaccinated with a dose of Varivax. On 23-MAR-2006, the patient was seen in the clinic and diagnosed with breakthrough chickenpox. He presented with more than 200 generalized lesions (some vesicular and some already scabbed). The reporter indicated that if possible she would obtain a vesicular fluid sample on 23-MAR-2006 or 27-MAR-2006 for varicella zoster virus identification, and if not, would send a scab. Results of the varicella zoster identification testing were received which indicated that an adequate scab specimen was collected on 23-MAR-2006, was sent to the laboratory on 27-MAR-2006, and was received in the laboratory on 31-MAR-2006. Varicella zoster virus DNA was amplified and the strain identification showed wild-type strain. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Culture throat negative, Erythema, Pharyngolaryngeal pain, Pyrexia, Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 7 year old male with no known history or allergies who on 09-DEC-1999 was vaccinated with a dose of Varivax. On 22-MAR-2006, the patient developed a sore throat and fever. On 22-MAR-2006, the patient developed a chickenpox breakthrough described as red spotted rash on torso, behind left ear and one on forehead. A strep throat test was performed and results were negative. As of 23-MAR-2006, the patient had not recovered. Additional information indicated that on 23-MAR-2006 the patient developed a mild case of chickenpox. He recovered approximately 1 week later. No further information is available.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning a 7 year old male with no known history or allergies who on 09-DEC-1999 was vaccinated with a dose of Varivax. On 22-MAR-2006, the patient developed a sore throat and fever. On 22-MAR-2006, the patient developed a chickenpox breakthrough described as red spotted rash on torso, behind left ear and one on forehead. A strep throat test was performed and results were negative. As of 23-MAR-2006, the patient had not recovered. Additional information indicated that on 23-MAR-2006 the patient developed a mild case of chickenpox. He recovered approximately 1 week later. No further information is available.
Age: 28.0
Sex: F
Vaccine: VARCEL
Symptoms: Blood human chorionic gonadotropin positive, Drug exposure during pregnancy, Seroconversion test negative
Clinical narrative: Information has been received through a pregnancy registry from a 28-year-old female with a history of hepatitis A and no allergies, who in June 2005 was vaccinated subcutaneously with a second dose of Varivax. There was no concomitant medication. On 02-OCT-2005, the patient determined that she was six weeks pregnant and her LMP date was 25-AUG-2005. On 02-OCT-2005, the patient underwent a seroconversion test for Varivax. Results of the test were negative. Unspecified medical attention was sought. At the time of the report the patient had not recovered. No product quality complaint was involved. Additional information has been requested.
Age: 40.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a physician concerning a 40 year old female employee with hypothyroidism who was vaccinated with a dose of Varivax. Concomitant therapy included SYNTHROID. On 21-MAR-2006 the patient had a titer performed the result of which was 0.71. It was reported that normal at "their lab" was greater than 0.89. The employee did not recall if she had been vaccinated with Varivax or had the disease in the past. Unspecified medical attention was sought. The patient's outcome was not recovered. There was no product quality complaint involved. Additional information has been requested.
Age: 2.0
Sex: M
Vaccine: VARCEL
Symptoms: Pruritus, Rash, Varicella
Clinical narrative: Information has been received from a physician concerning a 10-year-old hispanic male patient with an allergy to amoxicillin and no illness at the time of vaccination, who on 24-OCT-1997 (also reported as about one month prior to the report, on approximately 23-FEB-2006) was vaccinated with a dose of Varivax. There were no concomitant medications. The vaccination was not given in the reporting physician's office. On 01-MAR-2006 (also reported as in the week prior to the report, on approximately 16-MAR-2006) the patient developed a rash on his chest, abdomen and back along with mild itching. It was reported that the patient did not have a fever. He was seen in the physician's office on 03-MAR-2006 and was diagnosed with a mild case of chickenpox. The outcome was unknown. No product quality complaint was involved. No additional information is expected.
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test abnormal
Clinical narrative: Information has been received from a physician concerning a pregnant female who was possibly vaccinated with Varivax "in the past" and now has a low antibody titer. It was noted that the patient does not have chickenpox. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a woman working in a physician's office concerning a child who was vaccinated with a dose of Varivax. "Very recently," in 2006, the patient experienced breakthrough chickenpox. It was reported that the child was being boostered. It was also noted that the child was in an unspecified stage of breaking out with lesions. IT was reported that the patient's experience was currently ongoing. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Follow-up information from a physician indicated that he was aware of the breakthrough of chickenpox at the local school, but had "no idea" about any additional information. Additional information is not expected.
Age: 1.4
Sex: F
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a nurse practitioner concerning a female who on 20-OCT-2005 was vaccinated SQ with a 0.5 mL dose of Varivax. Recently the patient developed "full blown case" of chickenpox. The child had several hundred lesions and went to the ER. The patient's outcome was reported as recovered. There was no product quality complaint involved. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a physician concerning a female medical student who may have been vaccinated as a child with Varivax. On 24-MAR-2006 it was reported that the patient had a "recent" titer drawn which showed low immunity to varicella. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Age: 10.0
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 10 year old patient who on 31-AUG-1999 was vaccinated with Varivax, 0.5 mL single dose, subcutaneous. On 24-MAR-2006 the patient developed a breakthrough case of chickenpox lesions. The patient's outcome was not reported. Additional information is not expected.
Age: 2.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a 29 month old white male who was vaccinated with a first and second dose of Varivax on 16-JUL-1999 and 22-DEC-1999. It was reported that the patient developed chickenpox. The patient recovered. It was not specified if medical attention was sought. Additional information has been requested.
Age: 1.2
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 9 year old black female with mild asthma who on 15-JAN-1998 was vaccinated with a first dose of Varivax. On 18-MAR-2006 the patient developed obvious chickenpox with vesicular lesions on the trunk, extremities, scalp, and in the mouth. There was no prodrome or fever or history of positive contacts. Although the patient outcome was unknown, the reporter indicated that she expected the patient to have a full recovery. Additional information is not expected.
Age: 1.0
Sex: F
Vaccine: MMR, OPV, VARCEL
Symptoms: Nasopharyngitis, Rash, Varicella, Varicella post vaccine
Clinical narrative: Information has been received from LPN concerning an 8 year old female with microcephaly and a developmental delay who on 13-APR-1998 was vaccinated SC in the left arm with a first dose of Varivax (lot # 625131/0053H). Concomitant therapy that day included a first dose SC in the right arm of MMR II (lot # 619382/0102E) and a third dose PO of Orimune (lot 0787C). It was reported that the patient had cold symptoms 3-4 days prior to the rash. The "spots" started on 20-MAR-2006 and were multiplying by 22-MAR-2006. She was afebrile. She was seen at the office on 22-MAR-2006 with greater than 50 lesions and diagnosed with chickenpox. At the time of this report disease was "still active." Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Injection site abscess
Clinical narrative: Information has been received from a registered nurse concerning a patient who was vaccinated with a dose of Varivax (lot# 652557/1024R). Subsequently, the patient developed an abscess at the injection site. Follow up information from the registered nurse indicated that the patient was vaccinated with a dose of Varivax (lot # 649994/0553R). Two other patient's (WAES# 0603USA01435 and 0603USA01451) had a similar experiences following vaccination with Varivax (lot #649994/0553R). The reporter expressed a concern with the lot. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released by the regulatory agency. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 7 year old male who on 18-JUN-1999 was vaccinated SC with a first dose of Varivax (628242/1842H). On 18-MAR-2006 the patient developed chickenpox. Subsequently, the patient recovered. It was not specified if medical attention was sought. Additional information has been requested.
Age: 2.0
Sex: M
Vaccine: VARCEL
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Information has been received from a registered nurse concerning her 28 month old son who on 20-MAR-2006 was vaccinated in the leg with a dose of Varivax. On 24-MAR-2006 the patient developed fever and pain in his vaccinated leg. The patient was taken to his pediatrician but the physician did not think the symptoms were due to the vaccine. On 26-MAR-2006 the patient recovered. There was no product quality complaint involved. Additional information has been requested.
Age: 3.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 9 year old female who on 19-JUL-1999 was vaccinated with a 0.5 ml SC dose of Varivax. On 20-FEB-2006 the patient experienced breakthrough varicella. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning his middle school aged grandson who ten years ago, in approximately 1996, was vaccinated with a dose of Varivax. In March 2006 the patient experienced breakthrough varicella. It was noted that the patient had less than 50 lesions. Subsequently, the patient recovered from varicella on an unspecified date. No product quality complaint was involved. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a 4-year-old male who on 22-JAN-2003 was vaccinated with a dose of Varivax (Lot #641162/0797M). There was no concomitant therapy. The physician reported that on 07-MAR-2006 the patient developed shingles on his left arm and shoulder. The patient was not hospitalized and did not require any special treatment or medication. In March 2006, the patient's shingles resolved. Additional information has been requested.
Age: 6.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 6-7 year old male with asthma, eczema and unspecified allergies who in approximately 2000, at 12 months of age, was vaccinated with a dose of Varivax. Concomitant therapy included montelukast sodium (MSD) and inhaled corticosteroids (unspecified). On 28-MAR-2006 the patient presented with a chickenpox rash. There were greater than 50 lesions, but the areas of the body were not specified. There was no fever. The physician prescribed a topical antiviral and BENADRYL. There were no labs done. At the time of this report the patient had not recovered. No product quality complaint was involved. Additional information has been requested.
Age: 6.0
Sex: U
Vaccine: VARCEL
Symptoms: Rash macular, Rash papular, Rash vesicular, Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a health professional concerning a 6 year old child who on 06-JUN-2006 was vaccinated with a dose of Varivax. On 08-FEB-2006 the patient developed chickenpox. The child had too many lesions to count, near 500. The lesions were papular, vesicular and macular. Unspecified medical attention was sought. The patient was treated with acyclovir. There was no product quality complaint involved.  The reporter considered the patient's chickenpox to be an other important medical event. Additional information has been requested.
Age: 8.0
Sex: F
Vaccine: VARCEL
Symptoms: Pruritus, Skin lesion
Clinical narrative: Information has been received from a pharmacist concerning his 8 year old granddaughter with no pertinent medical history who was vaccinated with a dose of Varivax (lot # not provided). On 27 Mar 2006 the patient developed 12-24, itchy, bite-like lesions on her neck and torso. No other symptoms were noted. The patient outcome was reported as recovering. There was no product complaint involved. Additional information has been requested.
Age: 1.2
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Rash papular, Vaccination failure, Varicella
Clinical narrative: Information has been received from a physician concerning a 15 month old female with no pertinent medical history and no drug reactions/allergies who on 15 Mar 2006 was vaccinated SC in the right thigh with a first dose of Varivax (lot #647523/0633R). Concomitant therapy that day included a dose of MMR II vaccine. There was no illness at the time of vaccination. On 22 Mar 2006, one week post vaccination, the patient developed a papule rash, also reported as 19 pox mostly on her lower abdomen. The pox were reported to be small and drying, with some others scattered over her body. The patient was reported to be bright and alert. Unspecified medial attention was sought. There was no lab diagnostic studies performed. On 01 Apr 2006 the patient recovered. The patient had no adverse events following prior vaccination. There was no product quality complaint. Additional information is not expected.
Age: 1.2
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Decreased activity, Gastroenteritis viral, Irritability, Nasal congestion
Clinical narrative: Information has been received from a  health professional concerning a 7 year old female with no allergies or medical history who on 17-NOV-1999 was vaccinated in the left arm with a first SC dose of Varivax (lot # 631526/1014J). There was no illness at the time of vaccination and no concomitant medications. On 13-MAR-2006 the patient was cranky, had decreased activity, a runny nose and nasal congestion. On 14-MAR-2006 ten spots were noticed on the patient's neck/hairline/scalp. They were non-pruritic and there was no fever. On 15-MAR-2006 10 more spots erupted on the scalp, upper abdomen and arms. The majority of the vesicles were on her scalp. By 16-MAR-2006 the lesions were scabbed and there was no fever. It was noted that the lesions became itchy on the second day. No lab tests were done. The patient developed a stomach virus following the varicella. It was reported that the patient recovered. Additional information indicated that no medical attention was sought after the 18-MAR-2006 visit. The patient recovered on an unspecified date. No further information is available.
Age: 1.2
Sex: F
Vaccine: VARCEL
Symptoms: Rash pruritic, Rhinorrhoea, Scab, Skin lesion, Varicella
Clinical narrative: Information has been received from a  health professional concerning a 7 year old female with no allergies or medical history who on 17-NOV-1999 was vaccinated in the left arm with a first SC dose of Varivax (lot # 631526/1014J). There was no illness at the time of vaccination and no concomitant medications. On 13-MAR-2006 the patient was cranky, had decreased activity, a runny nose and nasal congestion. On 14-MAR-2006 ten spots were noticed on the patient's neck/hairline/scalp. They were non-pruritic and there was no fever. On 15-MAR-2006 10 more spots erupted on the scalp, upper abdomen and arms. The majority of the vesicles were on her scalp. By 16-MAR-2006 the lesions were scabbed and there was no fever. It was noted that the lesions became itchy on the second day. No lab tests were done. The patient developed a stomach virus following the varicella. It was reported that the patient recovered. Additional information indicated that no medical attention was sought after the 18-MAR-2006 visit. The patient recovered on an unspecified date. No further information is available.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Erythema, Pruritus, Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a health professional concerning an 8 year old Indian male with no allergies or medical history who on 08 Oct 1998 was vaccinated with Varivax. On 16 Mar 2006 the patient's mother noticed several flat fed small red spots. Some had a dark red center. There were about 12 spots total that were pruritic on the face, neck, chest, back and upper arm. There was no fever, no cold symptoms and no vesicles were visible. The patient was not acting ill. He was seen in the office on 21 Mar 2006. The spots were scabbed and there was no distress and no itching. The impression was ameliorated varicella. It was noted that the patient was exposed to varicella 2 weeks prior. No lab tests were done. The patient was considered recovered on 21 Mar 2006. No additional information was expected.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 7 year old male who on 23-SEP-1999, was vaccinated with subcutaneous Varivax. on 18-MAR-2006, the patient experienced mild breakthrough varicella. Subsequently, the patient recovered from mild breakthrough varicella. Additional information has been requested.
Age: 0.6
Sex: M
Vaccine: VARCEL
Symptoms: Inappropriate schedule of drug administration, Rash, Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a licensed practical nurse (LPN) concerning a 7 month old male with a penicillin allergy and a history of otitis media who on 27-APR-2002 was vaccinated with a dose of Varivax. There was no concomitant therapy. The LPN reported that on 21-MAR-2006, the patient developed a chickenpox rash. Unspecified medical attention was sought, but no treatment was ordered.  No laboratory or diagnostic testing was performed. Subsequently, the patient recovered from the chickenpox rash. No additional information is expected.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning a patient who on 15-OCT-1996 was vaccinated with a dose of Varivax. Subsequently, 14-MAR-2006, the patient developed breakthrough varicella. Unspecified medical attention was sought. There was no product quality complaint. No additional information is expected.
Age: 15.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 15-year-old female who was vaccinated with a dose of Varivax. The physician reported that the patient subsequently developed a breakthrough case of varicella. It was unknown if medical attention was sought. At the time of this report the outcome was unknown. No further information is available.
Age: 4.0
Sex: F
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from an individual in a physician's office concerning a 13 year old white female who on 21 Oct 1996 at 1:00 pm was vaccinated in the left arm with a first dose of Varivax. There was no illness at the time of vaccination. On 24 mar 2006, the patient had less then 50 lesions. "No adverse effects" were reported. No medical attention was sought. Additional information is not expected.
Age: 4.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a physician concerning a 4-year-old female with acute lymphoblastic leukemia (in remission) who on 16-AUG-2002 was vaccinated with a dose of Varivax. The physician reported that a varicella titer was checked after a course of chemotherapy and was negative for seroconversion. Medical attention was not sought. At the time of this report the outcome was unknown. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Varicella
Clinical narrative: Information has been received from a health professional concerning a 5 year old white male who on 29-JUN-2001 was vaccinated in the left thigh with a first dose of Varivax (lot # 638566/1886K). on 17-MAR-2006 the patient was seen with a rash on the trunk. He was seen again on 20-MAR-2006 and had <20 lesions on the trunk that were consistent with varicella. No labs or diagnostic tests were performed. Additional information has been requested.
Age: 8.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning an 8 year old female who was vaccinated with a dose of Varivax. In February 2006, the patient experienced a mild case of breakthrough chicken pox involving only 10 lesions. Unspecified medical attention was sought and the child subsequently recovered. No product quality complaint was involved. The patient's father ( WAES0604USA00481) experienced varicella after exposure to his son. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 12-month-old male who in March 2006, at "1 year of age," was vaccinated with a dose of Varivax. The RN reported that in 28-MAR-2006, the patient developed a generalized chickenpox breakthrough rash. Unspecified medical attention was sought. There was no fever or other associated symptoms. No treatment or laboratory/diagnostic tests were ordered. At the time of this report, the patient's generalized chickenpox breakthrough rash persisted. Additional information has been requested.
Age: 35.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning a 35 year old male who on 17 Mar 2006 was vaccinated with a dose of Varivax (lot #652663/1032R). A few days after vaccination, on 29 Mar 2006, the patient broke out with a varicella rash. He had about 10 lesions total, mostly on his chest and back. Unspecified medical attention was sought. At the time of the report, the patient was recovering. A product quality complaint was not involved. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a nurse practitioner concerning a 4 year old male who was vaccinated with a first SC dose of Varivax (Oka/Merck). The patient received his vaccination when he was 12 months of age. When he was 4 years old, it was reported that he had experienced three episodes of mild chickenpox. Subsequently, the patient recovered from mild chickenpox. No further information is available.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 12-month-old male who was vaccinated with a first dose of Varivax (Oka/Merck). Subsequently the patient experienced a varicella rash. Follow up information indicated that the patient was transferred to another primary care physician. It was also noted that the patient had a reaction after vaccination with hepatitis A virus vaccine inactivated (MSD) (0603USA04284). No additional information is expected.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning an approximately 10-11 year-old female who was vaccinated with a dose of Varivax (Oka/Merck). The physician reported that on approximately 03-MAR-2006, the patient developed a case of chickenpox. It was considered a more severe case of chickenpox and not a mild case as there were several lesions. The patient was not hospitalized. The patient's case of chickenpox was confirmed by a pediatrician. The patient's chickenpox subsequently resolved. Additional information has been requested.
Age: 2.58
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a health professional concerning a 31 month old male who on 12-AUG-2005, at 4:05 p.m., was vaccinated with a first dose in the left arm of Varivax (Oka/Merck) (Lot# 649261/0587P). On 22-MAR-2006 the patient broke out with less than 50 lesions. It was reported that the patient recovered. Additional information is not expected.
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a physician concerning an adult female who was vaccinated with the first and second doses, respectively, of Varivax. The physician reported that a varicella titer revealed the patient did not seroconvert. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a health professional concerning an 8 year old female, with no medical history and no allergies, who on 08-JUN-1998 was vaccinated with a dose of Varivax. There was no concomitant medication. On 31-MAR-2006 the patient was diagnosed by her pediatrician with chickenpox. The patient had approximately 30 to 50 lesions in her vagina, torso, scalp, and mouth. Some of the lesions appeared more like the wild type of varicella according to the reporter. There was no fever or other symptoms. The patient was ordered Benadryl and topical lotions. At the time of the report the patient was recovering. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a registered nurse concerning an 11 year old female who on 06-APR-2000 was vaccinated SC with a first dose of Varivax (lot 632369/1461J). Concomitant vaccinations administered that day included an IM fifth dose of DTaP, a SC fourth dose of poliovirus vaccine and a SC second dose of MMR II (lot # 654043/1716J). On 20-MAR-2006 that patient developed chickenpox. The child was seen by a physician and diagnosed with varicella. She had less than 50 lesions mainly covering the neck and stomach. She did not have a fever. NO treatment was ordered and no labs were done. There were no other symptoms. At the time of the report the patient had recovered. No product quality complaint was involved. Additional information is not expected.
Age: 6.0
Sex: F
Vaccine: VARCEL
Symptoms: Diarrhoea, Herpes zoster, Nausea, Rash vesicular
Clinical narrative: Information has been received from a physician concerning a 6-year-old female with a history of leukaemia, now in remission, who in 1998 was vaccinated in the right arm with a first dose of Varivax (Oka/Merck) (lot# 640725/0788M). It was unknown if there was illness at the time of vaccination and unknown if there was concomitant medications. On 13-MAR-2005 the patient developed a vesicular rash in the L1 dermatome associated with diarrhea and nausea. Unspecified medical attention was sought and she was diagnosed with zoster and treated with acyclovir. Subsequently, the patient recovered from zoster. Additional information is not expected.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash generalised, Vaccination failure
Clinical narrative: Information has been received from a registered nurse concerning a white male who on 04-SEP-1997 was vaccinated with a dose of Varivax. Subsequently, the patient developed a generalized rash. It was not localized at the injection site. There were 50-200 lesions. It was unknown if the patient had a cough or fever. The patient was not hospitalized. It was unknown if the rash was MD documented/evaluated. Vaccine failure was noted. Additional information has been requested.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash generalised, Vaccination failure
Clinical narrative: Information has been received from a registered nurse concerning a 10-year-old female who on 06-JAN-1997 was vaccinated with a dose of Varivax (Oka/Merck). Subsequently the patient developed a generalized rash of 50-200 lesions. The patient was not hospitalized. Vaccine failure was noted. This was not MD documented/evaluated. Follow up information indicated that there was no further information. No additional information is expected.
Age: 9.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning an approximately 9-year-old male who on 27-MAR-1997 was vaccinated with a dose of Varivax (Oka/Merck) (lot number unknown). Subsequently, on an unspecified date, the patient developed a rash. The patient was evaluated by a physician but was not hospitalized. No outcome information was reported. Additional information has been received on 05-JUL-2006 from a  unspecified woman who indicated that no further information is available on this patient. No further information is expected.